Search

Reglagene is proud to announce that we are the recipient of the Tucson Metro Chamber’s Start Up of the Year Award! Speaking on behalf of Reglagene’s employees and stakeholders, CEO Richard Austin said “All of us at Reglagene are elated to receive this honor. Our thanks go to the Chamber, Tech Parks Arizona, and most importantly the Tucson community for helping us build a great biotechnology company."


Reglagene’s Vice President of Discovery, Dr. Vijay Gokhale, will be presenting at the 2nd Annual Drug Discovery and Development Summit hosted by the Arizona Center for Drug Discovery and the University of Arizona Cancer Center. He will be presenting on the topic of controlling gene expression with small molecules for the treatment of cancer. This is a great opportunity for others to learn about the discovery process starting from screening to lead identification and development of small molecules.


More groundbreaking research in quadruplex science! On September 1st, Genome Biology published a paper revealing that scientists have directly observed RNA Quadruplex structures in nature for the first time. In July, University of Cambridge researchers directly observed DNA Quadruplex structures in human cells for the first time. These studies further validate the importance of Quadruplex structures in both DNA and RNA, which Reglagene’s Chief Scientific Officer Laurence Hurley has been studying for decades.


How Arabidopsis plants grow slower when RNA G-quadruplex is folded. Credit: John Innes Centre


Read more at the link below!


OFFICE

1703 E Mabel St
Tucson, AZ 85721
USA

www.reglagene.com  |  https://www.linkedin.com/company/reglagene/ | ©2020 by Reglagene Holding, Inc.